A similar effect was observed in the MIAPaCa‐2 and AsPC1 human pancreatic cancer cell lines, which carry ARID1A mutations or exhibit low ARID1A expression (Figure 5C). The gene discussed is ARID1A; the disease is pancreatic neoplasm.